STEPS: Substance Use Trial of E-cigarettes or Pharmacotherapy for Smoking
Part of paid clinical trials in Charleston, South Carolina.
- Sponsor
- Medical University of South Carolina
- Study ID
- NCT06922617
- Status
- Recruiting
Conditions
- Substance Use Disorders
- Tobacco Use
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Switching to E-Cigarette — BEHAVIORALParticipants will receive twelve weeks of e-cigarette products with instructions to switch completely at switch date
- Quitting using Medication — DRUGParticipants will receive twelve weeks of FDA approved medication, combination NRT, with instructions to quit smoking cigarettes at quit date
- Counseling — BEHAVIORALParticipants will recieve brief weekly counseling to support their quit or switch attempt from cigarettes.
Study Details
The purpose of this study is to investigate whether non-cigarette tobacco products, namely e-cigarettes (nicotine vapes), can help people who smoke and are in treatment for substance use disorder quit smoking by switching completely to e-cigarettes as compared to FDA-approved medications, namely nicotine replacement therapy in the form of patches and lozenges. Participation will last 6 months and will include five in-person study visits and eleven virtual assessments. Participants will also complete a short daily diary on their phones each day for the first twelve weeks. To qualify, participants must be within 30 days of SUD treatment program admission. This study is being conducted at three outpatient SUD treatment programs across South Carolina. These sites include: 1) the Center for Drug and Alcohol Problems (CDAP) in Charleston, SC, 2) Behavioral Health Services of Pickens County (BHSPC) in Pickens, SC, and 3) Shoreline Behavioral Health Services in Conway, SC. the Medical University of South Carolina in Charleston, SC, Behavioral Health Services in Pickens, SC, and the Medical University of South Carolina in Florence, SC.
Key Dates
- Start date
- Oct 17, 2025
- Status verified
- Apr 2026
- Primary completion
- Sep 1, 2028
- Completion
- Sep 1, 2028
Study Design
- Enrollment
- 240 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: MedicationThis arm includes participants randomly assigned to the medication group. Participants will receive combination nicotine replacement therapy (NRT). The NRT will consist of transdermal patches and nicotine lozenges. Participants will receive study product for 12 weeks.
- Experimental: Switching to an E-CigaretteThis arm includes participants randomly assigned to the E-Cigarette Group. Participants will receive a study-provided e-cigarette product for 12 weeks.
Primary Outcome Measure
Abstinence from smoking at end of treatment [ Time Frame: 7 days ]
Central Contacts
- Ela Williams(843) 876-2090
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| MUSC Charleston, Center for Drug and Alcohol Problems | Charleston | South Carolina | 29425 | |
| Shoreline Behavioral Health Services | Conway | South Carolina | 29526 | |
| Phoenix Center | Greenville | South Carolina | 29607 | |
| Behavioral Health Services of Pickens County | Pickens | South Carolina | 29671 |
Find similar trials in Charleston, SC
Related Studies
- RTMS Targets Neural Circuits for Smoking CessationRecruiting · Medical University of South Carolina · Charleston, South Carolina
- CARS: Cannabis and Alcohol Reduction StudyRecruiting · Medical University of South Carolina · Charleston, South Carolina
- COPEWeb Training for ProvidersRecruiting · VA Office of Research and Development · Charleston, South Carolina
- Development and Evaluation of a Virtual Reality Tool for At-Risk Trauma-Exposed Young PeopleRecruiting · Medical University of South Carolina · Charleston, South Carolina